| Trial ID: | L3740 |
| Source ID: | NCT04267601
|
| Associated Drug: |
Anagliptin
|
| Title: |
Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM
|
| Acronym: |
SSUG
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Anagliptin
|
| Outcome Measures: |
Primary: Change of HbA1C, after 24weeks treatment |
|
| Sponsor/Collaborators: |
Sponsor: JW Pharmaceutical
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
2448
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2017-07-06
|
| Completion Date: |
2021-09-30
|
| Results First Posted: |
|
| Last Update Posted: |
2021-04-29
|
| Locations: |
The Catholic University of Korea, Bucheon ST. Mary's hopsital, Bucheon, 14647, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT04267601
|
